Noah Medical Named Fierce 15 Company Behind Galaxy Robotic Bronchoscopy
San Carlos – October 12, 2026 -- Fierce MedTech has named Noah Medical one of its 2023 "Fierce 15" medical technology companies, citing the growth of the Galaxy System, the company's first commercial platform for robotic navigated bronchoscopy.
Fierce MedTech credited Noah Medical's long-term plan to improve early diagnosis and treatment across multiple indications. The Galaxy System is a fully image-integrated platform aimed at minimally invasive early lung cancer diagnosis.
Galaxy System reports 100% tool-in-lesion accuracy in human trial
Noah Medical reports that the Galaxy System achieved 100% successful navigation to lesion, 100% diagnostic yield and 95% tool-in-lesion accuracy in a preclinical trial. In a human trial, it reported 100% tool-in-lesion accuracy and 90-95% diagnostic yield. The figures are company-reported, and the source gives no trial sizes.